How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q2 2019?

66 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q2 2019. Use the holders table for investor-level position and value details.

Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Q: What does CUSIP 87184Q107 represent in this 13F holders report?

CUSIP 87184Q107 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 87184Q107

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 27,995,500
Total 13F shares: 31,644,913
Share change: +11,106,400
Total reported value: $291,721,875
Price per share: $9.26
Number of holders: 66
Value change: +$102,579,332
Number of buys: 49
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 87184Q107:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	18%	5,048,158	$46,140,000	—	31 Mar 2019	13F
ARK Investment Management LLC	13F	Company	11%	2,992,700	$27,353,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	7.2%	2,010,421	$18,375,000	—	31 Mar 2019	13F
Redmile Group, LLC	13F	Company	5.9%	1,645,200	$15,037,000	—	31 Mar 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	4.5%	1,268,945	$11,598,000	—	31 Mar 2019	13F
Samsara BioCapital, LLC	13F	Company	3.8%	1,059,938	$9,688,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	3.2%	901,936	$8,243,000	—	31 Mar 2019	13F
Amova Asset Management Americas, Inc.	13F	Company	2.4%	684,475	$6,256,000	—	31 Mar 2019	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	2.4%	684,475	$6,256,000	—	31 Mar 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	2.1%	574,835	$5,254,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	1.5%	420,892	$3,847,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	1.4%	401,072	$3,666,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	363,442	$3,322,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	1.1%	306,454	$2,801,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	290,531	$2,655,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.79%	220,500	$2,015,000	—	31 Mar 2019	13F
S.c.a. Candriam	13F	Individual	0.73%	204,000	$1,865,000	—	31 Mar 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.56%	157,275	$1,437,000	—	31 Mar 2019	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.42%	118,861	$1,086,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.4%	112,887	$1,032,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.4%	112,690	$1,030,000	—	31 Mar 2019	13F
WEDGE CAPITAL MANAGEMENT L L P/NC	13F	Company	0.3%	83,333	$762,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.3%	83,250	$761,000	—	31 Mar 2019	13F
ALPS ADVISORS INC	13F	Company	0.29%	81,287	$743,000	—	31 Mar 2019	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.26%	73,300	$670,000	—	31 Mar 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	69,715	$637,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.15%	42,419	$388,000	—	31 Mar 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.15%	41,000	$375,000	—	31 Mar 2019	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.14%	40,380	$369,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.14%	40,014	$366,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	39,754	$363,000	—	31 Mar 2019	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.14%	38,563	$352,000	—	31 Mar 2019	13F
Assenagon Asset Management S.A.	13F	Company	0.12%	34,500	$315,000	—	31 Mar 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.12%	34,400	$314,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.11%	32,061	$293,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.11%	31,401	$287,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.11%	29,742	$269,000	—	31 Mar 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.1%	27,109	$248,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.1%	27,100	$248,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.09%	24,079	$220,000	—	31 Mar 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.07%	18,539	$169,000	—	31 Mar 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.06%	16,275	$149,000	—	31 Mar 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.06%	16,132	$147,000	—	31 Mar 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	16,000	$146,000	—	31 Mar 2019	13F
ProShare Advisors LLC	13F	Company	0.05%	14,183	$130,000	—	31 Mar 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.04%	10,788	$99,000	—	31 Mar 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.04%	10,366	$95,000	—	31 Mar 2019	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.04%	10,190	$93,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	7,527	$69,000	—	31 Mar 2019	13F
BARCLAYS PLC	13F	Company	0.03%	7,449	$68,000	—	31 Mar 2019	13F

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q2 2019

As of 30 Jun 2019, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,644,913 shares. The largest 10 holders included FMR LLC, ARK Investment Management LLC, Redmile Group, LLC, Nikko Asset Management Americas, Inc., BlackRock Inc., VANGUARD GROUP INC, Samsara BioCapital, LLC, Sumitomo Mitsui Trust Holdings, Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and BAKER BROS. ADVISORS LP. This page lists 66 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.